A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/715 (2006.01) A01N 31/00 (2006.01) A01N 43/04 (2006.01) A01N 45/00 (2006.01) A61K 31/56 (2006.01) A61K 31/58 (2006.01)
Patent
CA 2165782
Glycosides having neotigogenin aglycone moieties, administered orally to mammals, are shown to inhibit the absorption of cholesterol. These compounds are useful in the treatment of hypercholesterolemia. Particular compounds are derived from tomato seeds and include neotigogenin trisaccharide.
On a démontré que des glycosides comportant des fractions d'aglycone de néotigogénine inhibent l'absorption de cholestérol, lorsqu'ils sont administrés par voie orale à des mammifères. Ces composés sont utiles dans le traitement de l'hypercholestérolémie. Des composés particuliers sont obtenus à partir de graines de tomate et on trouve parmi ceux-ci le trisaccharide de néotigogénine.
Oregon Regional Primate Research Center
Oyen Wiggs Green & Mutala Llp
LandOfFree
Cholesterol sequestrant glycosides that inhibit intestinal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cholesterol sequestrant glycosides that inhibit intestinal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cholesterol sequestrant glycosides that inhibit intestinal... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1977918